| Host: |
Rabbit |
| Applications: |
WB/ICC/IF |
| Reactivity: |
Human/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit monoclonal antibody anti-NUDT9 (284-297 aa) is suitable for use in Western Blot, Immunocytochemistry and Immunofluorescence research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
R07-9C3 |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
50mM Tris-Glycine (pH7.4) , 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA |
| Purification: |
Affinity Purified |
| Concentration: |
0.3 mg/ml |
| Dilution Range: |
WB 1:500-1:1000IF 1:50-1:200 |
| Storage Instruction: |
Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles. |
| Gene Symbol: |
NUDT9 |
| Gene ID: |
53343 |
| Uniprot ID: |
NUDT9_HUMAN |
| Immunogen Region: |
284-297 aa |
| Immunogen: |
A synthetic peptide of human NUDT9 |
| Tissue Specificity | Ubiquitously expressed but isoform 1 is the most predominant isoform. |
| Function | Hydrolyzes ADP-ribose (ADPR) to AMP and ribose 5'-phosphate. |
| Protein Name | Adp-Ribose Pyrophosphatase - MitochondrialAdp-Ribose DiphosphataseAdp-Ribose PhosphohydrolaseAdenosine Diphosphoribose PyrophosphataseAdpr-PpaseNucleoside Diphosphate-Linked Moiety X Motif 9Nudix Motif 9 |
| Database Links | Reactome: R-HSA-2393930 Q9BW91-1 |
| Cellular Localisation | Isoform 1: Mitochondrion |
| Alternative Antibody Names | Anti-Adp-Ribose Pyrophosphatase - Mitochondrial antibodyAnti-Adp-Ribose Diphosphatase antibodyAnti-Adp-Ribose Phosphohydrolase antibodyAnti-Adenosine Diphosphoribose Pyrophosphatase antibodyAnti-Adpr-Ppase antibodyAnti-Nucleoside Diphosphate-Linked Moiety X Motif 9 antibodyAnti-Nudix Motif 9 antibodyAnti-NUDT9 antibodyAnti-NUDT10 antibodyAnti-PSEC0099 antibodyAnti-UNQ3012 antibodyAnti-PRO9771 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
